Bare lymphocyte syndrome

Revision as of 17:14, 10 June 2009 by Brian Blank (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Bare lymphocyte syndrome
ICD-10 D81.6
OMIM 604571 209920
DiseasesDB 29570 Template:DiseasesDB2
MeSH D016511

WikiDoc Resources for Bare lymphocyte syndrome

Articles

Most recent articles on Bare lymphocyte syndrome

Most cited articles on Bare lymphocyte syndrome

Review articles on Bare lymphocyte syndrome

Articles on Bare lymphocyte syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bare lymphocyte syndrome

Images of Bare lymphocyte syndrome

Photos of Bare lymphocyte syndrome

Podcasts & MP3s on Bare lymphocyte syndrome

Videos on Bare lymphocyte syndrome

Evidence Based Medicine

Cochrane Collaboration on Bare lymphocyte syndrome

Bandolier on Bare lymphocyte syndrome

TRIP on Bare lymphocyte syndrome

Clinical Trials

Ongoing Trials on Bare lymphocyte syndrome at Clinical Trials.gov

Trial results on Bare lymphocyte syndrome

Clinical Trials on Bare lymphocyte syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bare lymphocyte syndrome

NICE Guidance on Bare lymphocyte syndrome

NHS PRODIGY Guidance

FDA on Bare lymphocyte syndrome

CDC on Bare lymphocyte syndrome

Books

Books on Bare lymphocyte syndrome

News

Bare lymphocyte syndrome in the news

Be alerted to news on Bare lymphocyte syndrome

News trends on Bare lymphocyte syndrome

Commentary

Blogs on Bare lymphocyte syndrome

Definitions

Definitions of Bare lymphocyte syndrome

Patient Resources / Community

Patient resources on Bare lymphocyte syndrome

Discussion groups on Bare lymphocyte syndrome

Patient Handouts on Bare lymphocyte syndrome

Directions to Hospitals Treating Bare lymphocyte syndrome

Risk calculators and risk factors for Bare lymphocyte syndrome

Healthcare Provider Resources

Symptoms of Bare lymphocyte syndrome

Causes & Risk Factors for Bare lymphocyte syndrome

Diagnostic studies for Bare lymphocyte syndrome

Treatment of Bare lymphocyte syndrome

Continuing Medical Education (CME)

CME Programs on Bare lymphocyte syndrome

International

Bare lymphocyte syndrome en Espanol

Bare lymphocyte syndrome en Francais

Business

Bare lymphocyte syndrome in the Marketplace

Patents on Bare lymphocyte syndrome

Experimental / Informatics

List of terms related to Bare lymphocyte syndrome

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Bare lymphocyte syndrome is a condition caused by deficiencies in major histocompatibility complex:

The bare lymphocyte syndrome, type II (BLS II) is a rare recessive genetic condition in which a group of genes called major histocompatibility complex class II (MHC class II) are not expressed. The result is that the immune system is severely compromised and cannot effectively fight infection. Clinically, this is known as a severe combined immunodeficiency (SCID).

The genetic basis for BLSII is not due to defects in the MHC II genes themselves. The genetic basis is the result of mutations in genes that code for proteins (transcription factors) that normally regulate the expression (gene transcription) of the MHC II genes. That is, one of the several proteins that are required to switch on MHC II genes in various cells types (primarily those in the immune system) is absent. The genes responsible were cloned by the laboratories of Bernard Mach[1] in Switzerland and Jeremy Boss[2] at Emory University in Atlanta, Georgia. Mutation in any one of four genes can lead to BLS II. The genes' names are: class II trans-activator (CIITA), regulatory factor of the X box 5 (RFX5), RFX-associated protein (RFXAP) and RFX ankyrin repeats (RFXANK; also known as RFXB).

Though BLSII is an attractive candidate for gene therapy , bone marrow transplant is currently the only treatment.

References

  1. Reith W, Mach B (2001). "The bare lymphocyte syndrome and the regulation of MHC expression". Annu. Rev. Immunol. 19: 331–73. doi:10.1146/annurev.immunol.19.1.331. PMID 11244040.
  2. DeSandro A, Nagarajan UM, Boss JM (1999). "The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes". Am. J. Hum. Genet. 65 (2): 279–86. PMID 10417269.

Template:SIB


Template:WikiDoc Sources